Japanese printing company Toppan Printing has bolstered its production of payment and access cards that incorporate an antibacterial agent in view of the prevailing Covid-19 pandemic.
The Tokyo-based company will increase the production capacity of payment and access cards by nearly 50% from July this year.
It is being claimed that the agent included in the making of the cards prevents bacterial growth by over 99%.
The cards have shown to specifically prevent E. coli and Staphylococcus aureus bacteria from procreating on the card surface.
These cards can be used in medical and pharmaceutical facilities as well as locations in which food is handled.
Toppan’s antibacterial cards are said to be compliant with the JIS Z 2801 standard for antibacterial activity on plastics.
Toppan’s business development manager in Secure Business Centre Hiroshi Shimada said: “With this increase in production capacity, we hope to help make a new normal possible and stimulate economic activity by driving cashless payments and responding to the need for improved hygiene in working and living environments.
“Toppan’s cards withstand the wear and tear of frequent use to retain antibacterial performance and are compatible with our self-operated instant issuance systems, which allow consumers to obtain new point or cash cards there and then.”